The International journal of artificial organs, cilt.42, sa.12, ss.765-769, 2019 (SCI-Expanded)
Objective: CytoSorb (R) hemadsorption is an adjunctive therapy in order to reduce elevated cytokine levels of interleukin-6, interleukin-1, and tumor necrosis factor alpha. Here we present a successful administration of CytoSorb (R) hemadsorption in an immunocompromised pediatric patient with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis.